Key result
Transthyretin fibrils impair cardiomyocyte contraction, alter calcium kinetics, and disrupt sarcomeric architecture.
Why the study?
To test whether in vitro deposited TTR disrupts cardiomyocyte adhesion complexes, altering calcium handling, force generation, and sarcomeric organization.
In vitro deposition of transthyretin fibrils directly impairs cardiomyocyte contractile function, calcium handling, and sarcomeric architecture, providing mechanistic insight into wtATTR-associated heart failure.
Answers are grounded in this paper and cite their sources.
Supports direct TTR fibril toxicity to cardiomyocytes; leaves open relevance to clinical wtATTR cardiomyopathy.
Age-related wild-type transthyretin amyloidosis (wtATTR) is characterized by systemic deposition of amyloidogenic fibrils of misfolded transthyretin (TTR) in the connective tissue of many organs. In the heart, this leads to age-related heart failure with preserved ejection fraction (HFpEF). The hypothesis tested is that TTR deposited in vitro disrupts cardiac myocyte cell-to-cell and cell-to-matrix adhesion complexes, resulting in altered calcium handling, force generation, and sarcomeric disorganization. Human iPSC-derived cardiomyocytes and neonatal rat ventricular myocytes (NRVMs), when grown on TTR-coated polymeric substrata mimicking the stiffness of the healthy human myocardium (10 kPa), had decreased contraction and relaxation velocities as well as decreased force production measured using traction force microscopy. Both NRVMs and adult mouse atrial cardiomyocytes had altered calcium kinetics with prolonged transients when cultured on TTR fibril-coated substrates. Furthermore, NRVMs grown on stiff (~GPa), flat or microgrooved substrates coated with TTR fibrils exhibited significantly decreased intercellular electrical coupling as shown by FRAP dynamics of cells loaded with the gap junction-permeable dye calcein-AM, along with decreased gap junction content as determined by quantitative connexin 43 staining. Significant sarcomeric disorganization and loss of sarcomere content, with increased ubiquitin localization to the sarcomere, were seen in NRVMs on various TTR fibril-coated substrata. TTR presence decreased intercellular mechanical junctions as evidenced by quantitative immunofluorescence staining of N-cadherin and vinculin. Current therapies for wtATTR are cost-prohibitive and only slow the disease progression; therefore, better understanding of cardiomyocyte maladaptation induced by TTR amyloid may identify novel therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Dittloff et al. (2022) studied Age-related wild-type transthyretin amyloidosis (wtATTR). TTR fibril-coated substrates was evaluated on Cardiomyocyte contraction, calcium kinetics, and sarcomeric architecture. Cardiomyocytes cultured on transthyretin fibril-coated substrates exhibited decreased contraction and relaxation velocities, altered calcium kinetics, and significant sarcomeric disorganization.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: